CoChat

Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models

Open access
Zhang, Qiuyang, Liu, Sen, Ge, Dongxia, Zhang, Qingsong, Xue, Yun, Xiong, Zhenggang, Abdel-Mageed, Asim B., Myers, Leann, Hill, Steven M., Rowan, Brian G., Sartor, Oliver, Melamed, Jonathan, Chen, Zhenbang, You, Zongbing · 2012 · Cancer Research
Cited by 98

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

The contributions of interleukin (IL)-17 to cancer remain unclear and somewhat controversial. We took a genetic approach to explore its role in prostate cancers by interbreeding IL-17 receptor C (IL-17RC)–deficient mice with mice that are conditionally mutant for PTEN, one established preclinical model for prostate cancer. Mice that were IL-17RC–deficient (IL-17RC−) displayed prostates that were smaller than mice that maintained IL-17RC expression (IL-17RC+). In addition, IL-17RC− mice developed a reduced number of invasive prostate adenocarcinomas with lower rates of cellular proliferation and higher apoptosis than IL-17RC+ mice. Moreover, the fibromuscular stroma surrounding prostatic glands was relatively thicker in IL-17RC− mice and was associated with decreased matrix metalloproteinase (Mmp)7 expression and increased Timp1, 2, and 4 expression, whereas administration of recombinant mouse IL-17 induced prostatic expression of Mmp7. Taken together, our results suggested that IL-17 promotes the formation and growth of prostate adenocarcinoma, and that an IL-17–MMP7 signaling axis is required for the transition of prostatic intraepithelial neoplasia to frank adenocarcinoma. Cancer Res; 72(10); 2589–99. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-3795

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 98

Metadata

Authors
Zhang, Q., Liu, S., Ge, D., Zhang, Q., Xue, Y., Xiong, Z., Abdel-Mageed, A. B., Myers, L., Hill, S. M., Rowan, B. G., Sartor, O., Melamed, J., Chen, Z., & You, Z.
Venue
Cancer Research
Published
2012-05-14
Volume
72
Issue
10
Pages
2589-2599
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2167892401
Cited by
98
References
8
FWCI
8.30
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-3795
The paper
Zhang, Q., Liu, S., Ge, D., Zhang, Q., Xue, Y., Xiong, Z., Abdel-Mageed, A. B., Myers, L., Hill, S. M., Rowan, B. G., Sartor, O., Melamed, J., Chen, Z., & You, Z. (2012). Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-3795

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.